Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda variable 11-55 (IGLV11-55) is a variable region gene segment of the human immunoglobulin lambda light chain locus, located on chromosome 22q11.2[3]. It is classified as a probable "non-functional open reading frame" (ORF), meaning that it generally cannot participate in the synthesis of a productive immunoglobulin light chain due to recombination defects, splicing errors, or conserved amino acid changes[1][3]. Immunoglobulins normally serve as receptors on B lymphocytes or as secreted antibodies in humoral immunity, but non-functional variable regions such as IGLV11-55 do not contribute to these processes[1][3]. The locus itself contains dozens of variable region genes, pseudogenes, and orphons that together expand immunoglobulin diversity but only a subset are functional[3]. IGLV11-55 is catalogued in immunogenetics databases due to gene mapping efforts, but has no evidence of direct biological or therapeutic relevance.
Null; no mechanism established for drug targeting
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin lambda variable 11-55 (IGLV11-55).